{"id":"F2017L01451","name":"Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)","slug":"statement-of-principles-concerning-ulnar-neuropathy-at-the-elbow-reasonable-hypothesis-no-65-of-2017","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":144253,"registerId":"commonwealth-F2017L01451-current","compilationNumber":null,"startDate":"2026-04-03","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)","content":"![Commonwealth Coat of Arms](image.001.png)\n\nStatement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)\n\nmade under subsection 196B(2) of the\n\nVeterans' Entitlements Act 1986\n\nCompilation No. 1\n\nCompilation date: 25 May 2020\n\nIncludes amendments up to: Amendment Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 44 of 2020) (F2020L00505)\n\nThe day of commencement of this Amendment Statement of Principles concerning ulnar neuropathy at the elbow is 25 May 2020.\n\nAbout this compilation\n\nThis compilation\n\nThis is a compilation of the Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017) that shows the text of the law as amended and in force on 25 May 2020.\n\nThe notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.\n\nUncommenced amendments\n\nThe effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.\n\nApplication, saving and transitional provisions for provisions and amendments\n\nIf the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.\n\nModifications\n\nIf the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.\n\nSelf‑repealing provisions\n\nIf a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.\n\n![RMA-Red](image.002.jpeg)\n\nStatement of Principles\n\nconcerning\n\nULNAR NEUROPATHY AT THE ELBOW  \n(Reasonable Hypothesis)\n\n(No. 65 of 2017)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\nDated 3 November 2017\n\n  \n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Application\n\n5 Definitions\n\n6 Kind of injury, disease or death to which this Statement of Principles relates\n\n7 Basis for determining the factors\n\n8 Factors that must exist\n\n9 Relationship to service\n\n10 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n  \n\n1 Name\n\nThis is the Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017).\n\n1 Commencement\n\nThis instrument commences on 4 December 2017.\n\n2 Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n3 Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n4 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n5 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about ulnar neuropathy at the elbow and death from ulnar neuropathy at the elbow.\n\nMeaning of ulnar neuropathy at the elbow\n\n(2) For the purposes of this Statement of Principles, ulnar neuropathy at the elbow means an acquired persistent disturbance of function of the ulnar nerve in the region of the elbow, in the presence of:\n\n(a) altered sensation, pain or weakness in the distribution of the ulnar nerve; and\n\n(b) electrodiagnostic evidence that confirms impaired ulnar nerve conduction across the elbow.\n\n> Note 1: Ulnar nerve dysfunction may be localised to the arcade of Struthers, the medial intermuscular septum of the arm, the retroepicondylar groove of the medial epicondyle, humeroulnar aponeurotic arcade (cubital tunnel), or the outlet from flexor carpi ulnaris muscle (deep flexor pronator aponeurosis).\n\n> Note 2: Ulnar neuropathy at the elbow may coexist with carpal tunnel syndrome.\n\nDeath from ulnar neuropathy at the elbow\n\n(3) For the purposes of this Statement of Principles, ulnar neuropathy at the elbow, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's ulnar neuropathy at the elbow.\n\n> Note: terminal event is defined in the Schedule 1 – Dictionary.\n\n6 Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that ulnar neuropathy at the elbow and death from ulnar neuropathy at the elbow can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\n> Note: relevant service is defined in the Schedule 1 – Dictionary.\n\n7 Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting ulnar neuropathy at the elbow or death from ulnar neuropathy at the elbow with the circumstances of a person's relevant service:\n\n(1) having a fracture of the bones of the affected elbow, including fracture of the medial epicondyle of the humerus, before the clinical onset of ulnar neuropathy at the elbow;\n\n(2) having trauma to the affected elbow within the two years before the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: trauma to the affected elbow is defined in the Schedule 1 - Dictionary.\n\n(3) performing repetitive and forceful activities involving flexion and extension of the affected elbow:\n\n(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and\n\n(b) where the repetitive and forceful activities have not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: Examples of repetitive and forceful activities include lifting, moving or carrying a load greater than ten kilograms, using hand saws or using large, hand-held power machinery, climbing vertical ladders, ammunitioning, using a hand-held piece of equipment such as a jackhammer or shovel, and overhead throwing.\n\n(4) holding a tool, device or instrument in position, with the wrist in an extended position and the affected elbow in a flexed position:\n\n(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and\n\n(b) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;\n\n(5) using the affected elbow as a support in a posture that is required as part of the activity being performed:\n\n(a) with the forearm pronated on a hard surface, or holding the arm with the elbow flexed by 30° or more; and\n\n(b) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and\n\n(c) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: Examples of using the elbow as a support include bicycling in the aero position, firing a hand-held weapon, or being required to adopt this posture due to undertaking activity in a cramped or confined space.\n\n(6) having a surgical procedure under general anaesthesia, within the two months before the clinical onset of ulnar neuropathy at the elbow;\n\n(7) having a surgical procedure to the affected elbow, including elbow arthroscopy, within the one year before the clinical onset of ulnar neuropathy at the elbow;\n\n(8) being hospitalised, or confined to bed in a supine position, for at least two days within the 30 days before the clinical onset of ulnar neuropathy at the elbow;\n\n(9) daily self-propulsion of a manual wheelchair:\n\n(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and\n\n(b) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;\n\n(10) having paraplegia at the time of the clinical onset of ulnar neuropathy at the elbow;\n\n(11) using elbow or forearm crutches:\n\n(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and\n\n(b) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;\n\n(12) having an inflammatory or degenerative joint disease from the specified list of inflammatory and degenerative joint diseases, involving the affected elbow, at the time of the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: specified list of inflammatory and degenerative joint diseases is defined in the Schedule 1 \\- Dictionary.\n\n(13) having amyloidosis at the time of the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: amyloidosis is defined in the Schedule 1 - Dictionary.\n\n(14) having haemodialysis or peritoneal dialysis for at least the one year before the clinical onset of ulnar neuropathy at the elbow;\n\n(15) having a cerebrovascular accident with hemiplegia, excluding transient ischaemic attack or transient symptoms with infarction, before the clinical onset of ulnar neuropathy at the elbow;\n\n(16) having an external burn to the affected arm requiring hospitalisation, within the five years before the clinical onset of ulnar neuropathy at the elbow;\n\n(17) being pregnant within the three months before the clinical onset of ulnar neuropathy at the elbow;\n\n(18) having an infection involving the affected ulnar nerve in the region of the elbow at the time of the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: Examples of an infection involving the affected ulnar nerve include Mycobacterium leprae (leprosy) and tuberculosis.\n\n(19) smoking at least ten pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of ulnar neuropathy at the elbow, and:\n\n(a) smoking commenced at least five years before the clinical onset of ulnar neuropathy at the elbow; and\n\n(b) where smoking has ceased, the clinical onset of ulnar neuropathy at the elbow has occurred within five years of cessation;\n\n> Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.\n\n(20) having a lesion as specified at the elbow that compresses or displaces the affected ulnar nerve at the time of the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: lesion as specified is defined in the Schedule 1 - Dictionary.\n\n(21) having diabetes mellitus at the time of the clinical onset of ulnar neuropathy at the elbow;\n\n(22) having acromegaly before the clinical onset of ulnar neuropathy at the elbow;\n\n> Note: acromegaly is defined in the Schedule 1 - Dictionary.\n\n(23) having a fracture of the bones of the affected elbow, including fracture of the medial epicondyle of the humerus, before the clinical worsening of ulnar neuropathy at the elbow;\n\n(24) having trauma to the affected elbow within the two years before the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: trauma to the affected elbow is defined in the Schedule 1 - Dictionary.\n\n(25) performing repetitive and forceful activities involving flexion and extension of the affected elbow:\n\n(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and\n\n(b) where the repetitive and forceful activities have not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: Examples of repetitive and forceful activities include lifting, moving or carrying a load greater than ten kilograms, using hand saws or using large, hand-held power machinery, climbing vertical ladders, ammunitioning, using a hand-held piece of equipment such as a jackhammer or shovel, and overhead throwing.\n\n(26) holding a tool, device or instrument in position, with the wrist in an extended position and the affected elbow in a flexed position:\n\n(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and\n\n(b) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;\n\n(27) using the affected elbow as a support in a posture that is required as part of the activity being performed:\n\n(a) with the forearm pronated on a hard surface, or holding the arm with the elbow flexed by 30° or more; and\n\n(b) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and\n\n(c) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: Examples of using the elbow as a support include bicycling in the aero position, firing a hand-held weapon, or being required to adopt this posture due to undertaking activity in a cramped or confined space.\n\n(28) having a surgical procedure under general anaesthesia, within the two months before the clinical worsening of ulnar neuropathy at the elbow;\n\n(29) having a surgical procedure to the affected elbow, including elbow arthroscopy, within the one year before the clinical worsening of ulnar neuropathy at the elbow;\n\n(30) being hospitalised, or confined to bed in a supine position, for at least two days within the 30 days before the clinical worsening of ulnar neuropathy at the elbow;\n\n(31) daily self-propulsion of a manual wheelchair:\n\n(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and\n\n(b) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;\n\n(32) having paraplegia at the time of the clinical worsening of ulnar neuropathy at the elbow;\n\n(33) using elbow or forearm crutches:\n\n(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and\n\n(b) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;\n\n(34) having an inflammatory or degenerative joint disease from the specified list of inflammatory and degenerative joint diseases, involving the affected elbow, at the time of the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: specified list of inflammatory and degenerative joint diseases is defined in the Schedule 1 \\- Dictionary.\n\n(35) having amyloidosis at the time of the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: amyloidosis is defined in the Schedule 1 - Dictionary.\n\n(36) having haemodialysis or peritoneal dialysis for at least the one year before the clinical worsening of ulnar neuropathy at the elbow;\n\n(37) having a cerebrovascular accident with hemiplegia, excluding transient ischaemic attack or transient symptoms with infarction, before the clinical worsening of ulnar neuropathy at the elbow;\n\n(38) having an external burn to the affected arm requiring hospitalisation, within the five years before the clinical worsening of ulnar neuropathy at the elbow;\n\n(39) being pregnant within the three months before the clinical worsening of ulnar neuropathy at the elbow;\n\n(40) having an infection involving the affected ulnar nerve in the region of the elbow at the time of the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: Examples of an infection involving the affected ulnar nerve include Mycobacterium leprae (leprosy) and tuberculosis.\n\n(41) smoking at least ten pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical worsening of ulnar neuropathy at the elbow, and:\n\n(a) smoking commenced at least five years before the clinical worsening of ulnar neuropathy at the elbow; and\n\n(b) where smoking has ceased, the clinical worsening of ulnar neuropathy at the elbow has occurred within five years of cessation;\n\n> Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.\n\n(42) having a lesion as specified at the elbow that compresses or displaces the affected ulnar nerve at the time of the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: lesion as specified is defined in the Schedule 1 - Dictionary.\n\n(43) having diabetes mellitus at the time of the clinical worsening of ulnar neuropathy at the elbow;\n\n(44) having acromegaly before the clinical worsening of ulnar neuropathy at the elbow;\n\n> Note: acromegaly is defined in the Schedule 1 - Dictionary.\n\n(45) inability to obtain appropriate clinical management for ulnar neuropathy at the elbow.\n\n8 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 8, must be related to the relevant service rendered by the person.\n\n(2) The factors set out in subsections 8(23) to 8(45) apply only to material contribution to, or aggravation of, ulnar neuropathy at the elbow where the person's ulnar neuropathy at the elbow was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n9 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 8 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\nSchedule 1 \\- Dictionary\n\nNote: See Section 5\n\n1 Definitions\n\nIn this instrument:\n\nacromegaly means a chronic disease of adults resulting from hypersecretion of growth hormone after closure of the epiphyses.\n\namyloidosis means the accumulation of insoluble fibrillar proteins in organs or tissues of the body such that vital function is compromised.\n\nlesion as specified means:\n\n(a) benign or malignant neoplasm;\n\n(b) bony fragment or foreign body;\n\n(c) calcification;\n\n(d) cyst;\n\n(e) ganglion;\n\n(f) gouty tophus;\n\n(g) haemorrhage or haematoma;\n\n(h) lymphoedema;\n\n(i) scar;\n\n(j) tuberculoma; or\n\n(k) another pathological lesion that compresses or displaces the ulnar nerve.\n\n> Note: This definition includes thickening, scarring or calcification of the ulnar collateral ligament.\n\nMRCA means the Military Rehabilitation and Compensation Act 2004.\n\npack-years of cigarettes, or the equivalent thereof in other tobacco products means a calculation of consumption where one pack-year of cigarettes equals 20 tailor-made cigarettes per day for a period of one calendar year, or 7 300 cigarettes. One tailor-made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight. One pack-year of tailor-made cigarettes equates to 7.3 kilograms of smoking tobacco by weight. Tobacco products mean cigarettes, pipe tobacco or cigars, smoked alone or in any combination.\n\nrelevant service means:\n\n(a) operational service under the VEA;\n\n(b) peacekeeping service under the VEA;\n\n(c) hazardous service under the VEA;\n\n(d) British nuclear test defence service under the VEA;\n\n(e) warlike service under the MRCA; or\n\n(f) non-warlike service under the MRCA.\n\n> Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\nspecified list of inflammatory and degenerative joint diseases means:\n\n(a) amyloid arthropathy;\n\n(b) gout;\n\n(c) haemophilic arthropathy;\n\n(d) neuropathic arthropathy;\n\n(e) nodular fasciitis;\n\n(f) osteoarthritis;\n\n(g) other inflammatory arthritis requiring treatment with a disease modifying agent or a biological agent;\n\n(h) rheumatoid arthritis;\n\n(i) sarcoidosis;\n\n(j) systemic lupus erythematosus; or\n\n(k) systemic sclerosis.\n\nterminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\ntrauma to the affected elbow means a discrete event involving the application of significant physical force to or through the affected elbow joint, that causes:\n\n(a) damage to the joint; and\n\n(b) the development, within 24 hours of the event occurring, of symptoms and signs of pain, tenderness and altered range of movement of the elbow joint. In the case of sustained unconsciousness or the masking of pain by analgesic medication, these symptoms and signs must appear on return to consciousness or the withdrawal of the analgesic medication; and\n\n(c) the persistence of these symptoms and signs for a period of at least seven days following their onset, save for where medical intervention for the trauma to that joint has occurred and that medical intervention involves one of the following:\n\n(i) immobilisation of the elbow joint by splinting or similar external agent;\n\n(ii) injection of a corticosteroid or local anaesthetic into that joint; or\n\n(iii) surgery to that joint.\n\n> Note: Examples of acute trauma include dislocation of the elbow joint, tearing or stretching of the ulnar collateral ligament, and medial epicondyle apophysitis.\n\nulnar neuropathy at the elbow—see subsection 6(2).\n\nVEA means the Veterans' Entitlements Act 1986.\n\n> Note: Endnotes\n\n> Note: Endnote 1—About the endnotes\n\nThe endnotes provide information about this compilation and the compiled law.\n\nThe following endnotes are included in every compilation:\n\nEndnote 1—About the endnotes\n\nEndnote 2—Abbreviation key\n\nEndnote 3—Legislation history\n\nEndnote 4—Amendment history\n\nAbbreviation key—Endnote 2\n\nThe abbreviation key sets out abbreviations that may be used in the endnotes.\n\nLegislation history and amendment history—Endnotes 3 and 4\n\nAmending laws are annotated in the legislation history and amendment history.\n\nThe legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.\n\nThe amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.\n\nMisdescribed amendments\n\nA misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.\n\nIf a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.\n\n> Note: Endnote 2—Abbreviation key\n\n|                                                | o = order(s)                        |\n| ---------------------------------------------- | ----------------------------------- |\n| ad = added or inserted                         | Ord = Ordinance                     |\n| am = amended                                   | orig = original                     |\n| amdt = amendment                               | par = paragraph(s)/subparagraph(s)  |\n| c = clause(s)                                  | /sub‑subparagraph(s)                |\n| C[x] = Compilation No. x                       | pres = present                      |\n| Ch = Chapter(s)                                | prev = previous                     |\n| def = definition(s)                            | (prev…) = previously                |\n| Dict = Dictionary                              | Pt = Part(s)                        |\n| disallowed = disallowed by Parliament          | r = regulation(s)/rule(s)           |\n| Div = Division(s)                              |                                     |\n| exp = expires/expired or ceases/ceased to have | reloc = relocated                   |\n| effect                                         | renum = renumbered                  |\n| F = Federal Register of Legislation            | rep = repealed                      |\n| gaz = gazette                                  | rs = repealed and substituted       |\n| LA = Legislation Act 2003                      | s = section(s)/subsection(s)        |\n| LIA = Legislative Instruments Act 2003         | Sch = Schedule(s)                   |\n| (md) = misdescribed amendment can be given     | Sdiv = Subdivision(s)               |\n| effect                                         | SLI = Select Legislative Instrument |\n| (md not incorp) = misdescribed amendment       | SR = Statutory Rules                |\n| cannot be given effect                         | Sub‑Ch = Sub‑Chapter(s)             |\n| mod = modified/modification                    | SubPt = Subpart(s)                  |\n| No. = Number(s)                                | underlining = whole or part not     |\n|                                                | commenced or to be commenced        |\n\n> Note: Endnote 3—Legislation history\n\n| Name                                                                                                                | Registration               | Commencement    | Application, saving and transitional provisions |\n| ------------------------------------------------------------------------------------------------------------------- | -------------------------- | --------------- | ----------------------------------------------- |\n| Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)           | 7 November 2017F2017L01451 | 4 December 2017 |                                                 |\n| Amendment Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 44 of 2020) | 28 April 2020F2020L00505   | 25 May 2020     |                                                 |\n\n> Note: Endnote 4—Amendment history\n\n| Provision affected                                        | How affected       |\n| --------------------------------------------------------- | ------------------ |\n| Schedule 1 – Dictionary – trauma to the affected elbow……… | rs. No. 44 of 2020 |","sortOrder":0}],"analysis":{"kimi_summary":{"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"The legislation maintains its original narrow scope. It addresses only ulnar neuropathy at the elbow for veterans' compensation purposes, with the 2020 amendment limited to refining the definition of 'trauma to the affected elbow' in the Dictionary. No scope creep is evident; the instrument remains tightly focused on its specific medical condition and claimant population."},"complexity_factors":["44 distinct factors with specific temporal requirements (e.g., 'within 2 years', 'at least 90 hours within 6 months', 'not ceased more than 30 days before')","22 factors for 'clinical onset' and 22 parallel factors for 'clinical worsening', creating mirrored structure","Multiple defined terms in Schedule 1 Dictionary (12 explicit definitions including nested definitions like 'lesion as specified' with 11 sub-categories)","Cross-references to other Statements of Principles (section 9) and external legislation (VEA and MRCA)","Technical medical terminology throughout (e.g., 'retroepicondylar groove', 'humeroulnar aponeurotic arcade', 'Mycobacterium leprae')","Specific quantitative thresholds requiring calculation (e.g., '10 pack-years', '7.3 kilograms of smoking tobacco', '30° or more' elbow flexion)","Conditional logic with multiple conjunctive requirements within single factors (e.g., factor 3 requires cumulative hours AND continuous period AND recency of cessation)"],"plain_english_summary":"This instrument sets medical rules (a Statement of Principles) for deciding when ulnar neuropathy at the elbow is linked to Australian military service, guiding claims under the Veterans' Entitlements Act and the Military Rehabilitation and Compensation Act. It lists 44 medical or activity-related factors — if at least one applies and is connected to service, a “reasonable hypothesis” of service causation exists, making compensation claims easier for current and former ADF members, peacekeepers and related personnel."},"flash_summary":{"complexity_score":6,"scope_assessment":{"changed":true,"description":"The compilation records an amendment (No. 44 of 2020) to Schedule 1: the definition of \"trauma to the affected elbow\" was revised. That definitional change affects which discrete elbow injuries qualify under the instrument's trauma‑related factors (sections referencing trauma), and so can alter the set of service events that satisfy the \"reasonable hypothesis\" link for affected claims."},"complexity_factors":["Large number of discrete factors (45) with parallel lists for onset and clinical worsening.","Multiple quantitative thresholds and temporal windows (e.g. 90 hours in 6 months; 60 hours; 30‑day cessation; 2 months; 1 year) that must be proved.","Technical medical criteria required (electrodiagnostic confirmation, clinical signs) and specialised definitions in the Dictionary (e.g. trauma, pack‑years, lesion as specified).","Conditional application rules — several factors (8(23)–8(45)) apply only to material contribution/aggravation where pre‑existing condition existed before/during service.","Cross‑references to other Statements of Principles: where a factor refers to another condition, that other SOP governs its application.","Evidentiary and proof burden on claimants to establish both the clinical diagnosis and the service‑related factor(s).","Mix of activity‑based occupational exposures and medical comorbidities (diabetes, amyloidosis, dialysis, pregnancy, smoking) requiring different types of evidence.","Detailed statutory definitions that narrow or expand scope (e.g. trauma definition with onset/persistence rules and medical‑intervention exceptions)."],"plain_english_summary":"**What this instrument does:** This Statement of Principles sets the medical definition of ulnar neuropathy at the elbow and lists the medical, surgical and service‑related factors that, if present, are sufficient to raise a \"reasonable hypothesis\" linking the condition (or death from it) to a person's relevant military service. It applies to veterans and members claiming under the VEA or MRCA. It matters because decision‑makers use these specified clinical signs, time limits and activity thresholds to decide entitlement to service‑related benefits."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-ulnar-neuropathy-at-the-elbow-reasonable-hypothesis-no-65-of-2017","history":"/api/acts/statement-of-principles-concerning-ulnar-neuropathy-at-the-elbow-reasonable-hypothesis-no-65-of-2017/history","analysis":"/api/acts/statement-of-principles-concerning-ulnar-neuropathy-at-the-elbow-reasonable-hypothesis-no-65-of-2017/analysis","conflicts":"/api/acts/statement-of-principles-concerning-ulnar-neuropathy-at-the-elbow-reasonable-hypothesis-no-65-of-2017/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-ulnar-neuropathy-at-the-elbow-reasonable-hypothesis-no-65-of-2017/important-cases","documents":"/api/acts/statement-of-principles-concerning-ulnar-neuropathy-at-the-elbow-reasonable-hypothesis-no-65-of-2017/documents"}}